Numerous studies have suggested that IL-8 and CXCR1/2 signaling play a role in recruiting neutrophil granulocytes to sites of inflammation; additionally, they contribute to tumor growth by promoting angiogenesis and immune resistance [12]. This evidence concerns the gene CXCL8 and neoplasm.